Article information
Abstract
Background
In patients with acute symptomatic pulmonary embolism (PE), embolic burden has an uncertain prognostic significance.
MethodsWe performed a meta-analysis of studies including patients with PE to assess the prevalence and prognostic relevance of central PE (i.e., saddle or main pulmonary emboli) for short-term death and other adverse outcome events. A random-effects model was used to pool study results, and I2 testing was used to test for heterogeneity.
ResultsData from 28 studies (205,877 patients) were included in the analysis. Of the 26 studies with 205,410 participants that enrolled consecutive patients with PE, 7748 (3.8%) had central PE. Though there was no statistically significant difference between central and noncentral PE for odds of short-term all-cause mortality (odds ratio [OR] 1.19; 95% confidence interval [CI], 0.91–1.55), central PE had a significant association with short-term PE-related deterioration or death (OR, 2.47; 95% CI, 1.44–4.25). Results from 9 studies with 4325 PE patients that had available data showed that central PE had a significant association with the odds of short-term PE-related mortality (OR, 1.77; 95% CI, 1.22–2.55). Results were consistent for prospective (OR, 1.67; 95% CI, 1.21–2.32), and studies that only enrolled stable patients (OR, 1.42; 95% CI, 1.06–1.92).
ConclusionsCentral PE was an uncommon finding in unselected patients diagnosed with PE. While central thrombus did not have an association with increased risk of all-cause mortality, it was significantly associated with an increased risk of PE-related deterioration and death short after diagnosis.
Keywords:
Pulmonary embolism
Prognosis
Mortality
Central
Saddle
Meta-analysis
Article
These are the options to access the full texts of the publication Archivos de Bronconeumología
References
[1]
S.Z. Goldhaber.
Venous thromboembolism: epidemiology and magnitude of the problem.
Best Pract Res Clin Haematol, 25 (2012), pp. 235-242
[2]
J.L. Lobo, S. Alonso, J. Arenas, P. Domènech, P. Escribano, C. Fernández-Capitán, et al.
Multidisciplinary consensus for the management of pulmonary thromboembolism.
Arch Bronconeumol, 58 (2022), pp. 246-254
[3]
B. Rivera-Lebron, M. McDaniel, K. Ahrar, A. Alrifai, D.M. Dudzinski, C. Fanola, et al.
Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT Consortium.
Clin Appl Thromb Hemost, 25 (2019),
[4]
G.A. Miller, G.C. Sutton.
Acute massive pulmonary embolism: clinical and haemodynamic findings in 23 patients studied by cardiac catheterization and pulmonary arteriography.
Br Heart J, 32 (1970), pp. 518-523
[5]
K.M. McIntyre, A.A. Sasahara.
Correlation of pulmonary photoscan and angiogram as measures of the severity of pulmonary embolic involvement.
J Nucl Med, 12 (1971), pp. 732-738
[6]
Urokinase Pulmonary Embolism Trial. Phase 1 results: a cooperative study.
JAMA, 214 (1970), pp. 2163-2172
[7]
K.E. Wood.
Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism.
Chest, 121 (2002), pp. 877-905
[8]
S. Konstantinides, G. Meyer, C. Becattini, H. Bueno, G.J. Geersing, V.P. Harjola, et al.
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).
Eur Heart J, 41 (2020), pp. 543-603
[9]
C.C. Jain, Y. Chang, C. Kabrhel, J. Giri, R. Channick, J. Rodriguez-Lopez, et al.
Impact of pulmonary arterial clot location on pulmonary embolism treatment and outcomes (90 days).
Am J Cardiol, 119 (2017), pp. 802-807
[10]
S. Bangalore, J.M. Horowitz, B. Dean, W.A. Jaber, S. Khandhar, C. Toma, et al.
Prevalence and predictors of cardiogenic shock in intermediate-risk pulmonary embolism.
JACC Cardiovasc Interv, 16 (2023), pp. 958-972
[11]
A. Senturk, S. Ozsu, S. Duru, E. Cakır, S.S. Ulaslı, E. Demirdogen, et al.
Prognostic importance of central thrombus in hemodynamically stable patients with pulmonary embolism.
Cardiol J, 24 (2017), pp. 508-514
[12]
W. Briceño, S. González, C. Rodríguez, A. Castillo, I. Jara, L. Lago, et al.
Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study.
Thromb Res, 244 (2024), pp. 109179
[13]
D. Jia, C. Ji, M. Zhao.
Saddle pulmonary embolism is not a sign of high-risk deterioration in non-high-risk patients: a propensity score-matched study.
World J Emerg Med, 12 (2021), pp. 261-267
[14]
D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, et al.
Meta-analysis of observational studies in epidemiology.
JAMA, 283 (2000), pp. 2008-2012
[15]
M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, et al.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
BMJ, 372 (2021), pp. n71
[16]
N.L. Wilczyinski, R.B. Haynes.
Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey.
BMC Med, 2 (2004), pp. 23
[17]
J.A. Hayden, P. Côté, C. Bombardier.
Evaluation of the quality of prognosis studies in systematic reviews.
Ann Intern Med, 144 (2006), pp. 427-437
[18]
J.P. Higgins, S.G. Thompson.
Quantifying heterogeneity in a meta-analysis.
Stat Med, 21 (2002), pp. 1539-1558
[19]
P. Pruszczyk, R. Pacho, M. Ciurzynski, M. Kurzyna, B. Burakowska, W. Tomkowski, et al.
Short term clinical outcome of acute saddle pulmonary embolism.
Heart, 89 (2003), pp. 335-336
[20]
A. Kaczynska, R. Pacho, A. Bochowicz, M. Szulc, M. Kostrubiec, A. Kuch-Wocial, et al.
Does saddle embolism influence short-term prognosis in patients with acute pulmonary embolism?.
Kardiol Pol, 62 (2005), pp. 119-127
[21]
W. Ghanima, M. Abdelnoor, L.O. Holmen, B.E. Nielssen, P.M. Sandset.
The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE.
J Intern Med, 261 (2007), pp. 74-81
[22]
J.H. Ryu, P.A. Pellikka, D.A. Froehling, S.G. Peters, G.L. Aughenbaugh.
Saddle pulmonary embolism diagnosed by CT angiography: frequency, clinical features and outcome.
Respir Med, 101 (2007), pp. 1537-1542
[23]
E. Gandara, G. Bose, P. Erkens, M. Rodgers, M. Carrier, P. Wells.
Outcomes of saddle pulmonary embolism: a nested case-control Study.
J Thromb Haemost, 9 (2011), pp. 867-869
[24]
A. Furlan, A. Aghayev, C.C. Chang, A. Patil, K.N. Jeon, B. Park, et al.
Short-term mortality in acute pulmonary embolism: clot burden and signs of right heart dysfunction at CT pulmonary angiography.
Radiology, 265 (2012), pp. 283-293
[25]
M.C. Vedovati, C. Becattini, G. Agnelli, P.W. Kamphuisen, L. Masotti, P. Pruszczyk, et al.
Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome.
Chest, 142 (2012), pp. 1417-1424
[26]
M.K. Kwak, W.Y. Kim, C.W. Lee, D.W. Seo, C.H. Sohn, S. Ahn, et al.
The impact of saddle embolism on the major adverse event rate of patients with non-high-risk pulmonary embolism.
Br J Radiol, 86 (2013), pp. 20130273
[27]
K.J. Choi, S.I. Cha, K.M. Shin, J.K. Lim, S.S. Yoo, J. Lee, et al.
Central emboli rather than saddle emboli predict adverse outcomes in patients with acute pulmonary embolism.
Thromb Res, 134 (2014), pp. 991-996
[28]
R. Pathak, S. Giri, P. Karmacharya, M.R. Aryal, A.A. Donato.
Comparison between saddle versus non-saddle pulmonary embolism: insights from Nationwide Inpatient Sample.
Int J Cardiol, 180 (2015), pp. 58-59
[29]
J.L. Alonso-Martínez, F.J. Anniccherico-Sanchez, M.A. Urbieta Echezarreta, I.V. García, J.R. Álvaro.
Central versus peripheral pulmonary embolism: Analysis of the impact on the physiological parameters and long-term survival.
N Am J Med Sci, 8 (2016), pp. 134-142
[30]
B. Gouin, M. Blondon, D. Jimenez, C. Fernández-Capitán, H. Bounameaux, S. Soler, et al.
Clinical prognosis of nonmassive central and noncentral pulmonary embolism: a registry-based cohort study.
Chest, 151 (2017), pp. 829-837
[31]
B. Alkinj, B.S. Pannu, D.R. Apala, A. Kotecha, R. Kashyap, V.N. Iyer.
Saddle vs nonsaddle pulmonary embolism: clinical presentation, hemodynamics, management, and outcomes.
Mayo Clin Proc, 92 (2017), pp. 1511-1518
[32]
N. Akhoundi, T.F. Langroudi, H. Rajebi, S. Haghi, M. Paraham, S. Karami, et al.
Computed tomography pulmonary angiography for acute pulmonary embolism: prediction of adverse outcomes and 90-day mortality in a single test.
Pol J Radiol, 84 (2019), pp. e436-e446
[33]
R. Hajizadeh, S. Ghaffari, H. Rajebi, H. Kavandi, E. Javanshir, G. Fahimi, et al.
Short-term mortality of patients with saddle pulmonary embolism: a single-center study.
Turk Kardiyol Dern Ars, 47 (2019), pp. 273-280
[34]
M. Tavoly, J. Gleditsch, J.P. Ghanima, F. Bremtun, M. Schintzkewitz, K.J. Thrane, et al.
The mean bilateral proximal extension of the clot is associated with pulmonary embolism severity parameters and management-associated outcomes.
Acta Radiol, 62 (2021), pp. 1309-1316
[35]
W.H. Ibrahim, S.D. Al-Shokri, M.S. Hussein, A. Kamel, L.M. Abu Afifeh, G. Karuppasamy, et al.
Saddle versus non-saddle pulmonary embolism: differences in the clinical, echocardiographic, and outcome characteristics.
Libyan J Med, 17 (2022), pp. 2044597
[36]
J. Gleditsch, Ø. Jervan, F. Klok, R. Holst, E. Hopp, M. Tavoly, et al.
Acta Radiol Open, 12 (2023),
[37]
J. Hu, X. Tian, X.W. Liu, Y.Z. Liu, B.L. Gao, C.Y. Li.
Markers of right ventricular dysfunction predict 30-day adverse prognosis of pulmonary embolism on pulmonary computed tomographic angiography.
Medicine (Baltimore), 102 (2023),
[38]
A. Isath, R. Shah, D. Bandyopadhyay, A. Bali, A. Kanwal, D. Spevack, et al.
Am J Cardiol, 201 (2023), pp. 341-348
[39]
R.V. Hofstetter, O. Stalder, T. Tritschler, M. Méan, N. Rodondi, M. Righini, et al.
Clinical characteristics and prognosis of patients with central pulmonary embolism.
J Thromb Haemost, 23 (2025), pp. 1585-1595
[40]
H.M. Al-Dorzi, F.M. Almutawa, B.A. AlRuhaymi, A.O. Alhusaini, A.M. Alnamlah, A.M.B. Shaman, et al.
Characteristics, management and outcomes of central versus peripheral pulmonary embolism: a retrospective cohort study.
Thromb J, 23 (2025), pp. 22
[41]
S. Ozsu, K. Karaman, A. Mentese, A. Ozsu, S.C. Karahan, I. Durmus, et al.
Combined risk stratification with computerized tomography/echocardiography and biomarkers in patients with normotensive pulmonary embolism.
Thromb Res, 126 (2010), pp. 486-492
[42]
J.R. Park, S.A. Chang, S.Y. Jang, H.J. No, S.J. Park, S.H. Choi, et al.
Evaluation of right ventricular dysfunction and prediction of clinical outcomes in acute pulmonary embolism by chest computed tomography: comparisons with echocardiography.
Int J Cardiovasc Imaging, 28 (2012), pp. 979-987
[43]
F.G. Meinel, J.W. Nance, J. Schoepf, V.S. Hoffmann, K.M. Thierfelder, P. Costello, et al.
Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis.
Am J Med, 128 (2015), pp. 747-759
[44]
M.C. Vedovati, F. Germini, G. Agnelli, C. Becattini.
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis.
J Thromb Haemost, 11 (2013), pp. 2092-2102
[45]
D. Sánchez, J. De Miguel, A. Sam, C. Wagner, C. Zamarro, R. Nieto, et al.
The effects of cause of death classification on prognostic assessment of patients with pulmonary embolism.
J Thromb Haemost, 9 (2011), pp. 2201-2207
[46]
D. Jimenez, B. Bikdeli, C. Rodríguez, A. Muriel, A. Ballaz, S. Soler, et al.
Identification of low-risk patients with acute symptomatic pulmonary embolism.
Arch Bronconeumol, 59 (2023), pp. 575-580
[47]
T. Tritschler, N. Kraaijpoel, P. Girard, H.R. Büller, N. Langlois, M. Righini, et al.
Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: communication from the SSC of the ISTH.
J Thromb Haemost, 18 (2020), pp. 1495-1500
